BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38305717)

  • 1. Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.
    Nguyen DL; Lotfalla M; Cimino-Mathews A; Habibi M; Ambinder EB
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230060. PubMed ID: 38305717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.
    Kim Y; Jung HK; Park AY; Ko KH; Jang H
    Acta Radiol; 2022 Aug; 63(8):1032-1042. PubMed ID: 34260322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI.
    Jirarayapong J; Chikarmane SA; Portnow LH; Farah S; Gombos EC
    J Magn Reson Imaging; 2024 May; 59(5):1725-1739. PubMed ID: 37534882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.
    Bae SJ; Cha YJ; Eun NL; Ji JH; Kim D; Lee J; Ahn SG; Son EJ; Jeong J
    Radiology; 2021 Oct; 301(1):47-56. PubMed ID: 34254854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
    Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
    AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
    Bazzocchi M; Zuiani C; Panizza P; Del Frate C; Soldano F; Isola M; Sardanelli F; Giuseppetti GM; Simonetti G; Lattanzio V; Del Maschio A
    AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
    Torous VF; Resteghini NA; Phillips J; Dialani V; Slanetz PJ; Schnitt SJ; Baker GM
    Arch Pathol Lab Med; 2021 Oct; 145(10):1264-1269. PubMed ID: 33450753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy.
    Bae SJ; Ahn SG; Park EJ; Eun NL; Kim JH; Ji JH; Kook Y; Jang JS; Baek SH; Cha YJ; Jeong J
    Radiology; 2023 Apr; 307(2):e221777. PubMed ID: 36749210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging appearance of noncalcified and calcified DCIS.
    Scott-Moncrieff A; Sullivan ME; Mendelson EB; Wang L
    Breast J; 2018 May; 24(3):343-349. PubMed ID: 29139591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Accuracy of Mammography, Ultrasound, and Magnetic Resonance Imaging For the Measurement of Invasive Breast Cancer With Extensive Intraductal Components.
    Kim YE; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
    Clin Breast Cancer; 2023 Jan; 23(1):45-53. PubMed ID: 36328930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
    J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmass enhancement lesions of the breast on core needle biopsy: outcomes, frequency of malignancy, and pathologic findings.
    Bartels AK; Fadare O; Hasteh F; Zare SY
    Hum Pathol; 2021 May; 111():92-97. PubMed ID: 33722650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound.
    Xiao L; Simmons C; Khanani S
    Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Patients with Invasive Lobular Carcinoma.
    Yoon J; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY
    Korean J Radiol; 2020 Aug; 21(8):946-954. PubMed ID: 32677379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
    Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
    Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging.
    Kwon BR; Chang JM; Kim SY; Lee SH; Shin SU; Yi A; Cho N; Moon WK
    Korean J Radiol; 2020 Nov; 21(11):1210-1219. PubMed ID: 32729267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
    Amato F; Bicchierai G; Cirone D; Depretto C; Di Naro F; Vanzi E; Scaperrotta G; Bartolotta TV; Miele V; Nori J
    Radiol Med; 2019 Dec; 124(12):1229-1237. PubMed ID: 31773458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Targeted Ultrasound to Predict Malignancy Among Lesions Detected on Contrast-Enhanced Digital Mammography.
    Coffey K; Sung J; Comstock C; Askin G; Jochelson MS; Morris EA; D'Alessio D
    AJR Am J Roentgenol; 2021 Sep; 217(3):595-604. PubMed ID: 33025811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.